Cargando…
TSC22D4 interacts with Akt1 to regulate glucose metabolism
Maladaptive insulin signaling is a key feature in the pathogenesis of severe metabolic disorders, including obesity and diabetes. Enhancing insulin sensitivity represents a major goal in the treatment of patients affected by diabetes. Here, we identify transforming growth factor–β1 stimulated clone...
Autores principales: | Demir, Sevgican, Wolff, Gretchen, Wieder, Annika, Maida, Adriano, Bühler, Lea, Brune, Maik, Hautzinger, Oksana, Feuchtinger, Annette, Poth, Tanja, Szendroedi, Julia, Herzig, Stephan, Ekim Üstünel, Bilgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586482/ https://www.ncbi.nlm.nih.gov/pubmed/36269831 http://dx.doi.org/10.1126/sciadv.abo5555 |
Ejemplares similares
-
Emerging Targets in Type 2 Diabetes and Diabetic Complications
por: Demir, Sevgican, et al.
Publicado: (2021) -
Control of diabetic hyperglycaemia and insulin resistance through TSC22D4
por: Ekim Üstünel, Bilgen, et al.
Publicado: (2016) -
Loss of TSC1/TSC2 sensitizes immune
checkpoint blockade in non–small cell lung cancer
por: Huang, Qingyuan, et al.
Publicado: (2022) -
Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function
por: Wolff, Gretchen, et al.
Publicado: (2022) -
Lipocalin 13 enhances insulin secretion but is dispensable for systemic metabolic control
por: Bühler, Lea, et al.
Publicado: (2021)